Genomic Health Test Spares Women Unncessary Radiation
Dec 7, 2011, 11:25 AM
by
Michael Croft
USA TODAY | According to results presented at the San Antonio Breast Cancer Symposium, a new 12-gene test from Genomic Health could spare thousands of women diagnosed with ductal carcinoma in situ (DCIS) annually by predicting which cases are most likely to be aggressive — requiring both surgery and radiation — versus surgery alone.
December 7, 2011 | A new 12-gene test from Genomic Health could spare many of the 45,000 American women diagnosed with ductal carcinoma in situ (DCIS) annually by predicting which cases are most likely to be aggressive — requiring both surgery and radiation — versus surgery alone. The results were presented at the San Antonio Breast Cancer Symposium. USA Today